Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
Clinical trial NCT01003184 · COMPLETED
Trial details
- NCT number
- NCT01003184
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2011-07-01
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.